°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå : Á¦Ç° À¯Çüº°, ¹è¼Û ½Ã½ºÅÛº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
Transcatheter Heart Valve Market, By Product Type, By Delivery Systems, By End User, and By Region
»óǰÄÚµå : 1789517
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,351,000
Unprintable PDF & Excel (Single User License)
US $ 7,000 £Ü 9,880,000
PDF & Excel (Multi User License - Up to 7 Users)
US $ 10,000 £Ü 14,115,000
PDF & Excel (Corporate User License)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀåÀº 2025³â¿¡´Â 59¾ï 3,000¸¸ ´Þ·¯, 2032³â¿¡´Â 147¾ï 5,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2032³â±îÁöÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 13.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 59¾ï 3,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â¤¤ ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø±â°£ 2025-2032³â CAGR : 13.90% 2032³â °¡Ä¡ ¿¹Ãø 147¾ï 5,000¸¸ ´Þ·¯

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· À̽ÄÀº ½ÉÀå ÆÇ¸·Áõ(VHD) Ä¡·á¸¦ À§ÇØ »ýü Àΰø ÆÇ¸·À¸·Î ¼Õ»óµÈ ½ÉÀå ÆÇ¸·À» º¹±¸ÇÏ´Â Àú ħ½À ½ÉÀå ¼ö¼úÀÔ´Ï´Ù. ÀüÅëÀûÀÎ °³½É¼úÀ» ´ëüÇÏ´Â Á¢±Ù¹ýÀÌ¸ç Æ¯È÷ À§ÇèÀÌ ¸Å¿ì ³ôÀº ȯÀÚ¿¡°Ô ±ÇÀåµË´Ï´Ù. ´ëµ¿¸ÆÆÇÀº ¿ÞÂÊ ÇÏ´Ü ½É½Ç(Á½ɽÇ)°ú ½ÅüÀÇ ÁÖµ¿¸Æ(´ëµ¿¸Æ) »çÀÌ¿¡ ÀÖ½À´Ï´Ù. ¹ëºê°¡ Á¦´ë·Î ¿­¸®Áö ¾ÊÀ¸¸é ½ÉÀå¿¡¼­ ¸öÀ¸·ÎÀÇ Ç÷·ù°¡ °¨¼ÒÇÕ´Ï´Ù. °æÄ«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú(TAVR)Àº ÁõÈļº ´ëµ¿¸Æ ÆÇ¸· ÇùÂøÁõÀ» ¾Î°í ÀÖÀ¸¸ç, Ç¥ÁØ ÆÇ¸· ġȯ¼úÀÇ À§ÇèÀÌ ³ôÀº »ç¶÷ÀÇ Ä¡·á¸¦ À§ÇØ ¹Ì±¹ FDA¿¡ ÀÇÇØ ½ÂÀεǾú½À´Ï´Ù. TAVRÀº Ç÷·ù¸¦ ȸº¹½Ã۰í ÈäÅë, È£Èí °ï¶õ, ½Ç½Å, ÇÇ·Î¿Í °°Àº ´ëµ¿¸Æ ÆÇ¸· ÇùÂøÁõÀÇ Â¡ÈÄ¿Í Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. TAVRÀº ¼ö¼ú ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú(°³½É¼ú)À¸·Î ÀÎÇÑ ÇÕº´ÁõÀÇ À§ÇèÀÌÀÖ´Â »ç¶÷ÀÇ ¼±ÅÃÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼¼°è ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϱâ À§ÇØ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ Àμö¿Í °°Àº ¹«±âÀû ¼ºÀå Àü·«ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 6¿ù ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ SMT´Â ±¸Á¶Àû ½ÉÀå ÀÇ·á±â±âÀÎ Vascular Concepts¸¦ ÀμöÇÏ¿© ½ÃÀå¿¡ ÁøÀÔÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº°, 2020³â-2032³â

Á¦5Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå, ¹è¼Û ½Ã½ºÅÛº°, 2020³â-2032³â

Á¦6Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2020³â-2032³â

Á¦7Àå ¼¼°èÀÇ °æ Ä«Å×ÅÍ ½ÉÀ庯 ½ÃÀå, Áö¿ªº°, 2020³â-2032³â

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ¼½¼Ç

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Transcatheter Heart Valve Market is estimated to be valued at USD 5.93 Bn in 2025 and is expected to reach USD 14.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.93 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.90% 2032 Value Projection: USD 14.75 Bn

Transcatheter heart valve implantation is a minimally-invasive heart procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. The aortic valve is located between the left lower heart chamber (left ventricle) and the body's main artery (aorta). If the valve does not open correctly, blood flow from the heart to the body is reduced. Transcatheter aortic valve replacement (TAVR) is approved by the U.S. FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. TAVR can help restore blood flow and reduce the signs and symptoms of aortic valve stenosis - such as chest pain, shortness of breath, fainting and fatigue. TAVR may be an option for people who are at risk of complications from surgical aortic valve replacement (open-heart surgery). Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2020, SMT, a manufacturer of medical equipment, announced that it has acquired structural heart medical device firm Vascular Concepts, to enter into the market.

Key features of the study

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Transcatheter Heart Valve Market, By Product and Services, 2020 - 2032, (USD Bn)

5. Global Transcatheter Heart Valve Market, By Delivery Systems, 2020 - 2032, (USD Bn)

6. Global Transcatheter Heart Valve Market, By End User, 2020 - 2032, (USD Bn)

7. Global Transcatheter Heart Valve Market, By Region, 2020 - 2032, (USD Bn)

8. Competitive Landscape

9. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â